Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Operating expenses
Research and development	$ 641,572	$ 361,484
Selling, general and administrative	2,199,412	2,753,482
Total operating expenses	2,840,984	3,114,966
Loss from operations	(2,840,984)	(3,114,966)
Other expenses:
Impairment loss		(500,000)
Interest expense	(172,825)	(82,594)
Total other expenses	(172,825)	(582,594)
Net loss	(3,013,809)	(3,697,560)
Net loss attributable to the non-controlling interest	(95,581)
Net loss attributable to the controlling interest	(2,918,228)	(3,697,560)
Deemed dividend on preferred stock	782,879	627,705
Net loss applicable to controlling interest common stockholders	$ (3,701,107)	$ (4,325,265)
Basic and diluted	$ (0.28)	$ (0.34)
Weighted average number of common shares outstanding – basic and diluted	13,333,143	12,859,938